| EIGENSTRAT |
drug |
4 |
4 |
|
| eIPSC |
phenotype |
3 |
2 |
eIPSC, evoked inhibitory postsynaptic currents, inhibitory postsynaptic current |
| elastic net |
drug |
2 |
1 |
|
| ELAVL1 |
gene |
2 |
1 |
Hu, RNA binding protein Hu |
| elderly subjects |
cohort |
2 |
— |
|
| electronic health records |
cohort |
5 |
3 |
EHR, EHRs |
| Electrophysiological measures |
phenotype |
5 |
2 |
Electrophysiological endophenotypes, Electrophysiology, endophenotypic markers |
| eLORETA |
drug |
2 |
2 |
|
| Elovl5 |
gene |
3 |
1 |
ELOVL fatty acid elongase 5, Elongation of very long chain fatty acids protein 5, Elovl5 |
| embryoid bodies |
phenotype |
2 |
4 |
EBs |
| embryonic lethality |
phenotype |
4 |
1 |
dying on embryonic day 10 |
| embryos |
cohort |
3 |
1 |
embryonic samples |
| eMERGE network |
cohort |
3 |
3 |
eMERGE |
| emerging adulthood |
cohort |
8 |
3 |
age 18–29, ages 23-27, emerging adulthood, emerging adults, young adulthood, young adults |
| EMMAX |
drug |
2 |
— |
|
| Emotion |
phenotype |
36 |
26 |
E6, E6: Positive Emotions, emotional signals |
| emotional abuse |
phenotype |
6 |
3 |
childhood emotional abuse, emotional abuse from peers, emotional maltreatment |
| emotional and behavioral problems |
phenotype |
9 |
4 |
behavioral problems, behavioural problems, emotional problems |
| emotional disorders |
phenotype |
2 |
1 |
|
| Emotional disturbance |
phenotype |
3 |
3 |
affective instability, chronic feelings of emptiness, intense anger |
